Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 Black Phoenix Black Phoenix +336.77%
#4 aPriori aPriori +120.78%
#5 Bedrock Bedrock +76.11%
#6 Cysic Cysic +49.09%
#7 Prom Prom +41.94%
#8 Playnance Playnance +35.13%
#9 COTI COTI +25.33%
#10 Nillion Nillion +24.72%
Coin of the day
Wrapped One Wrapped One
설정
언어
한국어
통화
USD
테마
Kaleido Biosciences, Inc. Kaleido Biosciences, Inc.

Kaleido Biosciences, Inc.

KLDO
주식 순위 #42678
Kaleido Biosciences, Inc. is a clinical-stage healthcare firm dedicated to... Kaleido Biosciences, Inc. is a clinical-stage healthcare firm dedicated to pioneering microbiome metabolic therapies. Its pipeline includes specific drug candidates such as KB195 for urea cycle disorders, KB295 targeting ulcerative colitis, KB174 aimed at hepatic encephalopathy, and KB109 for COVID-19. The company is also advancing programs in other significant therapeutic areas, including multi-drug resistant infections, chronic kidney disease, atherosclerotic cardiovascular disease, cardio-metabolic syndrome, immuno-oncology, and various inflammatory bowel conditions. Kaleido maintains strategic collaborations with Institute Gustave Roussy, Washington University, and Janssen. Established in 2015, its headquarters are situated in Lexington, Massachusetts.
주가
$0.00001
마지막 동기화: 2026-07-30
시가총액
$426.00
변동 (1일)
0.00%
변동 (1년)
-90.00%
국가
US
거래 Kaleido Biosciences, Inc. (KLDO)

카테고리

Healthcare
Kaleido Biosciences, Inc. (KLDO)의 주가 이력
최고 종가: $0.00 (2026-07-01 기준)

최저 종가: $14.23 (2019-02-01 기준)
Kaleido Biosciences, Inc.의 주가 이력 (2019 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) 0.00%
2025 304.60%
2024 7.34%
2023 -92.98%
2022 -99.97%
2021 -65.59%
2020 50.15%
2019 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $527.87 36.13%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $873.57 37.02%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $736.38 8.73%
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $263.09 20.45%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -5.56%
KR